| RS398124157 |
FGD1
|
Health Risk |
Conflicting classifications of pathogenicity |
History of neurodevelopmental disorder, FGD1-related disorder |
| RS398124159 |
FGD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124160 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS398124161 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS398124162 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS398124166 |
GPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Wilms tumor 1 |
| RS398124167 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS398124169 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS398124170 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, See cases |
| RS398124172 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS398124175 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS398124177 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Inborn genetic diseases |
| RS398124178 |
RPS6KA3
|
Health Risk |
Pathogenic |
— |
| RS398124181 |
LARGE1
|
Health Risk |
Pathogenic |
— |
| RS398124182 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS398124183 |
LARGE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS398124185 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS398124191 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS398124192 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS398124196 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome 1 |
| RS398124197 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124198 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS398124199 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS398124201 |
FOXG1
|
Health Risk |
Conflicting classifications of pathogenicity |
FOXG1 disorder, Inborn genetic diseases |
| RS398124202 |
FOXG1;FOXG1-AS1;LINC01551
|
Health Risk |
Pathogenic/Likely pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS398124204 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, Inborn genetic diseases |
| RS398124206 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS398124208 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS398124209 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS398124210 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS398124211 |
SOX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS398124220 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS398124221 |
MOGS
|
Health Risk |
Conflicting classifications of pathogenicity |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS398124224 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS398124225 |
SEC23B
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS398124226 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS398124227 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124229 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS398124230 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS398124231 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS398124232 |
SLC16A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124234 |
FTCD
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutamate formiminotransferase deficiency, Inborn genetic diseases |
| RS398124236 |
GJB6
|
Health Risk |
Pathogenic |
— |
| RS398124237 |
GJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1B, Autosomal recessive nonsyndromic hearing loss 1A |
| RS398124239 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS398124241 |
ZIC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 5, Holoprosencephaly 5 |
| RS398124243 |
POMT1
|
Health Risk |
Likely pathogenic |
— |
| RS398124244 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS398124245 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS398124247 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS398124253 |
TRIM32
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS398124254 |
MLYCD
|
Health Risk |
Pathogenic |
— |
| RS398124257 |
ATP6V0A2
|
Health Risk |
Pathogenic |
— |
| RS398124259 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS398124264 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS398124265 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS398124268 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS398124269 |
ACAD8
|
Health Risk |
Pathogenic |
— |
| RS398124274 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS398124275 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124276 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124277 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124278 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124280 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS398124281 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS398124282 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, See cases |
| RS398124283 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124284 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS398124287 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS398124289 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS398124292 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Disorders of Intracellular Cobalamin Metabolism |
| RS398124294 |
MMACHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cobalamin C disease, Cobalamin C disease |
| RS398124295 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS398124296 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, MMACHC-related disorder |
| RS398124297 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS398124298 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS398124299 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS398124300 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124301 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS398124303 |
OPA1
|
Health Risk |
Pathogenic |
Autosomal dominant optic atrophy classic form, Optic atrophy with or without deafness |
| RS398124307 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS398124308 |
FOXRED1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, Leigh syndrome |
| RS398124309 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS398124310 |
POMGNT1
|
Health Risk |
Pathogenic |
— |
| RS398124311 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS398124313 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS398124315 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS398124317 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS398124319 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS398124320 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS398124321 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS398124322 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS398124323 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, CHARGE syndrome |
| RS398124324 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS398124330 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, VPS13B-related disorder |
| RS398124333 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS398124339 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS398124341 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS398124343 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS398124345 |
SLC35C1
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency type II, Leukocyte adhesion deficiency type II |